2021 ASCO Annual meeting
03 Jun 2021
This Friday marks the beginning of the 2021 ASCO Annual meeting, where MRC Clinical Trials Unit at UCL will be presenting results from colorectal and prostate cancer trials.
The 2021 ASCO Annual meeting is a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care. It will take place as an online-only event between Friday 4 June and Tuesday 8 June.
Details of the MRC CTU at UCL presentations taking place at ASCO 2021 are shown below.
| Time | Session Type | Title | Authors | Abstract link |
|
Friday 4 June 2:00 pm BST |
Poster Session | Copy number profiles of primary tumors for risk stratification of advanced prostate cancer: A biomarker study embedded in the multicenter STAMPEDE trial. | Grist et al. | View abstract |
|
Friday 4 June 2:00 pm BST |
Poster Session | Proliferation index and survival in men with prostate cancer starting long-term androgen deprivation therapy in the STAMPEDE clinical trial. | Mendes et al. | View abstract |
|
Monday 7 June 6:15 pm BST |
Oral Abstract Session | Oral maintenance capecitabine versus active monitoring for patients with metastatic colorectal cancer (mCRC) who are stable or responding after 16 weeks of first-line treatment: Results from the randomized FOCUS4-N trial. | Adams et al. | View abstract |
Further information